Abreo Adrian P, Glidden David, Painter Patricia, Lea Janice, Herzog Charles A, Kutner Nancy G, Johansen Kirsten L
Department of Epidemiology & Biostatistics, University of California, San Francisco, CA, USA.
BMC Nephrol. 2014 Nov 15;15:177. doi: 10.1186/1471-2369-15-177.
New information from various clinical settings suggests that tight blood pressure control may not reduce mortality and may be associated with more side effects.
We performed cross-sectional multivariable ordered logistic regression to examine the association between predialysis blood pressure and the short physical performance battery (SPPB) in a cohort of 749 prevalent hemodialysis patients in the San Francisco and Atlanta areas recruited from July 2009 to August 2011 to study the relationship between systolic blood pressure and objective measures of physical function. Mean blood pressure for three hemodialysis sessions was analyzed in the following categories: <110 mmHg, 110-129 mmHg (reference), 130-159 mmHg, and ≥160 mmHg. SPPB includes three components: timed repeated chair stands, timed 15-ft walk, and balance tests. SPPB was categorized into ordinal groups (≤6, 7-9, 10-12) based on prior literature.
Patients with blood pressure 130-159 mmHg had lower odds (OR 0.57, 95% CI 0.35-0.93) of scoring in a lower SPPB category than those whose blood pressure was between 110 and 129 mmHg, while those with blood pressure≥160 mmHg had 0.56 times odds (95% CI 0.33-0.94) of scoring in a lower category when compared with blood pressure 110-129 mmHg. When individual components were examined, blood pressure was significantly associated with chair stand (130-159 mmHg: OR 0.59, 95% CI 0.38-0.92) and gait speed (≥160 mmHg: OR 0.59, 95% CI 0.35-0.98). Blood pressure≥160 mmHg was not associated with substantially higher SPPB score compared with 130-159 mmHg.
Patients with systolic blood pressure at or above 130 mmHg had better physical performance than patients with lower blood pressure in the normotensive range. The risk-benefit tradeoff of aggressive blood pressure control, particularly in low-functioning patients, should be reexamined.
来自各种临床环境的新信息表明,严格的血压控制可能不会降低死亡率,并且可能与更多副作用相关。
我们进行了横断面多变量有序逻辑回归,以研究2009年7月至2011年8月在旧金山和亚特兰大地区招募的749例维持性血液透析患者队列中透析前血压与简短身体功能量表(SPPB)之间的关联,以研究收缩压与身体功能客观指标之间的关系。分析了三次血液透析治疗的平均血压,分为以下类别:<110 mmHg、110 - 129 mmHg(参考值)、130 - 159 mmHg和≥160 mmHg。SPPB包括三个部分:定时重复起坐、15英尺定时步行和平衡测试。根据先前文献,将SPPB分为有序组(≤6、7 - 9、10 - 12)。
血压在130 - 159 mmHg的患者与血压在110至129 mmHg之间的患者相比,在较低SPPB类别中得分的几率较低(OR 0.57,95% CI 0.35 - 0.93),而血压≥160 mmHg的患者与血压110 - 129 mmHg的患者相比,在较低类别中得分的几率为0.56倍(95% CI 0.33 - 0.94)。当检查各个组成部分时,血压与起坐(130 - 159 mmHg:OR 0.59,95% CI 0.38 - 0.92)和步态速度(≥160 mmHg:OR 0.59,95% CI 0.35 - 0.98)显著相关。与130 - 159 mmHg相比,血压≥160 mmHg与SPPB得分大幅升高无关。
收缩压在130 mmHg及以上的患者比血压在正常血压范围内较低的患者身体表现更好。应重新审视积极血压控制的风险效益权衡,尤其是在功能低下的患者中。